Literature DB >> 9834077

Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.

J M Soos1, J Morrow, T A Ashley, B E Szente, E K Bikoff, S S Zamvil.   

Abstract

Astrocytes are nonprofessional APCs that may participate in Ag presentation and activation of pathogenic CD4+ T cells involved in central nervous system (CNS) inflammatory diseases. Using immortalized pure astrocytes as a complement to the study of primary astrocytes, we investigated whether these astrocytes express elements involved in the class II endocytic pathway and if they are capable of processing native myelin basic protein (MBP), a step that could be necessary for initiating or perpetuating T cell recognition of this self-Ag in vivo. Upon IFN-gamma-stimulation, primary and immortalized astrocytes up-regulate class II transactivator (CIITA), invariant chain (Ii) (p31 and p41), H-2Ma, and H-2Mb. Analysis of CIITA cDNA sequences demonstrated that CIITA transcription in astrocytes is directed by a promoter (type IV) that mediates IFN-gamma-inducible CIITA expression and encodes a CIITA protein that differs in its N-terminal sequence from CIITA reported in professional APC. Comparing live and fixed APC for Ag presentation, we show that Ag processing by APC is required for presentation of native MBP to autopathogenic T cells specific for the major MBP epitope, Acl-11. We have observed that primary astrocytes and some, but not all, astrocyte lines in the absence of contaminating microglia are capable of processing and presenting native MBP, suggesting that there may be heterogeneity. Our study provides definitive evidence that astrocytes are capable of processing CNS autoantigen, indicating that astrocytes have potential for processing and presentation of CNS autoantigen to proinflammatory T cells in CNS autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  Microarray analysis of IFN-gamma response genes in astrocytes.

Authors:  Sandra K Halonen; Tyson Woods; Kate McInnerney; Louis M Weiss
Journal:  J Neuroimmunol       Date:  2006-04-21       Impact factor: 3.478

Review 3.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 4.  Exocytosis in astrocytes: transmitter release and membrane signal regulation.

Authors:  Alenka Guček; Nina Vardjan; Robert Zorec
Journal:  Neurochem Res       Date:  2012-04-21       Impact factor: 3.996

Review 5.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.

Authors:  Alexei Verkhratsky; Michela Matteoli; Vladimir Parpura; Jean-Pierre Mothet; Robert Zorec
Journal:  EMBO J       Date:  2016-01-12       Impact factor: 11.598

Review 6.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

Authors:  Burkhard Becher; Ingo Bechmann; Melanie Greter
Journal:  J Mol Med (Berl)       Date:  2006-06-14       Impact factor: 4.599

7.  Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.

Authors:  Guoping Jiang; Horng-Ren Yang; Lianfu Wang; Gary M Wildey; John Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

8.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 9.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

10.  Fingolimod Suppresses the Proinflammatory Status of Interferon-γ-Activated Cultured Rat Astrocytes.

Authors:  Saša Trkov Bobnar; Matjaž Stenovec; Katarina Miš; Sergej Pirkmajer; Robert Zorec
Journal:  Mol Neurobiol       Date:  2019-01-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.